Harish V. Pai

947 total citations
19 papers, 761 citations indexed

About

Harish V. Pai is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Harish V. Pai has authored 19 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in Harish V. Pai's work include Pharmacogenetics and Drug Metabolism (8 papers), Redox biology and oxidative stress (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Harish V. Pai is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Redox biology and oxidative stress (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Harish V. Pai collaborates with scholars based in India and United States. Harish V. Pai's co-authors include John J. Mieyal, David W. Starke, Suparna Qanungo, Shankar J. Chinta, Edward J. Lesnefsky, Charles L. Hoppel, Vijayalakshmi Ravindranath, Anna‐Liisa Nieminen, Michael R. Boyd and Sudarshan C. Upadhya and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Harish V. Pai

18 papers receiving 744 citations

Peers

Countries citing papers authored by Harish V. Pai

Since Specialization

Citations

This map shows the geographic impact of Harish V. Pai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harish V. Pai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harish V. Pai more than expected).

Fields of papers citing papers by Harish V. Pai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harish V. Pai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harish V. Pai. The network helps show where Harish V. Pai may publish in the future.

Co-authorship network of co-authors of Harish V. Pai

This figure shows the co-authorship network connecting the top 25 collaborators of Harish V. Pai. A scholar is included among the top collaborators of Harish V. Pai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harish V. Pai. Harish V. Pai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Identification, characterization and control of a sequence variant in monoclonal antibody drug product: a case study 2021 ·Scientific Reports ·(unknown), (unknown), Avik Ghosh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Harish V. Pai, (unknown)	9
2	Physicochemical and Functional Characterization of trastuzumab-dkst, a Trastuzumab Biosimilar 2021 ·Future Medicinal Chemistry ·Parag Goyal, (unknown), (unknown), (unknown), (unknown), Harish V. Pai, (unknown), (unknown), (unknown), Gaurav Mehta, Arindam Saha, (unknown), (unknown), Maninder Kaur, Ankita Singh, (unknown), (unknown), Jeffrey W. Smith, (unknown), (unknown)	1
3	Identification and quantification of product-related quality attributes in bio-therapeutic monoclonal antibody via a simple, and robust cation-exchange HPLC method compatible with direct online detection of UV and native ESI-QTOF-MS analysis 2018 ·Journal of Chromatography B ·(unknown), (unknown), (unknown), (unknown), Harish V. Pai, (unknown), (unknown)	15
4	Characterization and similarity assessment of a pegfilgrastim biosimilar MYL-1401H. 2018 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Harish V. Pai, (unknown), (unknown), Parag Goyal, (unknown), Jeffrey W. Smith, (unknown)	1
5	T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab 2017 ·PLoS ONE ·(unknown), Arindam Saha, (unknown), (unknown), (unknown), (unknown), Swati Patel, (unknown), (unknown), Enrique Montero, Harish V. Pai, (unknown), (unknown), Pradip Nair	39
6	Aging-dependent changes in rat heart mitochondrial glutaredoxins—Implications for redox regulation 2013 ·Redox Biology ·(unknown), Suparna Qanungo, Harish V. Pai, David W. Starke, (unknown), Hisashi Fujioka, Edward J. Lesnefsky, János Kerner, M. Rosca, Charles L. Hoppel, John J. Mieyal	32
7	Glutaredoxin Regulates Apoptosis in Cardiomyocytes via NFκB Targets Bcl-2 and Bcl-xL: Implications for Cardiac Aging 2009 ·Antioxidants and Redox Signaling ·Molly Gallogly, Melissa D. Shelton, Suparna Qanungo, Harish V. Pai, David W. Starke, Charles L. Hoppel, Edward J. Lesnefsky, John J. Mieyal	65
8	Targeted disruption of the glutaredoxin 1 gene does not sensitize adult mice to tissue injury induced by ischemia/reperfusion and hyperoxia 2007 ·Free Radical Biology and Medicine ·Ye-Shih Ho, Ye Xiong, (unknown), Jinping Gao, Balvin H.L. Chua, Harish V. Pai, John J. Mieyal	86
9	Glutathione Supplementation Potentiates Hypoxic Apoptosis by S-Glutathionylation of p65-NFκB 2007 ·Journal of Biological Chemistry ·Suparna Qanungo, David W. Starke, Harish V. Pai, John J. Mieyal, Anna‐Liisa Nieminen	134
10	What is the Functional Significance of the Unique Location of Glutaredoxin 1 (GRx1) in the Intermembrane Space of Mitochondria? 2007 ·Antioxidants and Redox Signaling ·Harish V. Pai, David W. Starke, Edward J. Lesnefsky, Charles L. Hoppel, John J. Mieyal	87
11	Unique cytochromes P450 in human brain: implication in disease pathogenesis 2006 ·PubMed ·V Ravindranath, Reddy Peera Kommaddi, Harish V. Pai	13
12	Activation of Pregnane X Receptor Disrupts Glucocorticoid and Mineralocorticoid Homeostasis 2006 ·Molecular Endocrinology ·Yonggong Zhai, Harish V. Pai, Jie Zhou, Janet A. Amico, Regis R. Vollmer, Wen Xie	69
13	Presence of splice variant forms of cytochrome P4502D1 in rat brain but not in liver 2005 ·Molecular Brain Research ·Shankar J. Chinta, Harish V. Pai, Vijayalakshmi Ravindranath	6
14	RESPONSE TO COMMENT ON “A FRAMESHIFT MUTATION AND ALTERNATE SPLICING IN HUMAN BRAIN GENERATE A FUNCTIONAL FORM OF THE PSEUDOGENE CYTOCHROME P4502D7 THAT DEMETHYLATES CODEINE TO MORPHINE” 2005 ·Drug Metabolism and Disposition ·Harish V. Pai, Vijayalakshmi Ravindranath	0
15	A Frameshift Mutation and Alternate Splicing in Human Brain Generate a Functional Form of the Pseudogene Cytochrome P4502D7 That Demethylates Codeine to Morphine 2004 ·Journal of Biological Chemistry ·Harish V. Pai, Reddy Peera Kommaddi, Shankar J. Chinta, Toshiyuki Mori, Michael R. Boyd, Vijayalakshmi Ravindranath	50
16	Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite 2002 ·The Pharmacogenomics Journal ·Harish V. Pai, Sudarshan C. Upadhya, Shankar J. Chinta, (unknown), V Ravindranath	34
17	Toxicological Consequences of Differential Regulation of Cytochrome P450 Isoforms in Rat Brain Regions by Phenobarbital 2002 ·Archives of Biochemistry and Biophysics ·Sudarshan C. Upadhya, Shankar J. Chinta, Harish V. Pai, Michael R. Boyd, Vijayalakshmi Ravindranath	24
18	Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD 2002 ·Protein Expression and Purification ·Sidharth Chopra, Harish V. Pai, Anand Ranganathan	36
19	Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain 2002 ·Molecular Brain Research ·Shankar J. Chinta, Harish V. Pai, Sudarshan C. Upadhya, Michael R. Boyd, Vijayalakshmi Ravindranath	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact